Company ObsEva SA Swiss Exchange
Equities
OBSN
CH1260041939
Biotechnology & Medical Research
Business Summary
Number of employees: 15
Sales per Business
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Women's Reproductive, Health and Pregnancy Therapeutics
100.0
%
| 0 | nan % | 19 | 100.0 % | - |
Sales per region
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 0 | nan % | 19 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 146,919,237 | 103,079,787 ( 70.16 %) | 29,741,950 ( 20.24 %) | 70.16 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
OBSEVA SA 22.97% | 33,741,950 | 22.97% | 45,552 $ |
Company contact information
![address ObsEva SA(OBSN)](https://cdn.zonebourse.com/static/address/44934222.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+24.40% | 27.87B | |
-17.74% | 20.95B | |
-15.73% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |